Asaf Danziger
2016
In 2016, Asaf Danziger earned a total compensation of $1.6M as Chief Executive Officer at NovoCure, a 84% decrease compared to previous year.
Compensation breakdown
| Option Awards | $652,694 |
|---|---|
| Salary | $651,272 |
| Other | $276,483 |
| Total | $1,580,449 |
Danziger received $652.7K in option awards, accounting for 41% of the total pay in 2016.
Danziger also received $651.3K in salary and $276.5K in other compensation.
Rankings
In 2016, Asaf Danziger's compensation ranked 6,008th out of 14,075 executives tracked by ExecPay. In other words, Danziger earned more than 57.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,008 out of 14,075 | 57th |
Division Manufacturing | 2,187 out of 5,489 | 60th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 294 out of 827 | 64th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 159 out of 510 | 69th |
Industry Surgical and Medical Instruments and Apparatus | 86 out of 313 | 73rd |
Source: SEC filing on March 28, 2017.
Danziger's colleagues
We found three more compensation records of executives who worked with Asaf Danziger at NovoCure in 2016.